Roadzen (NASDAQ:RDZN – Get Free Report) and Ryan Specialty (NYSE:RYAN – Get Free Report) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, risk and earnings.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Roadzen and Ryan Specialty, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Roadzen | 0 | 0 | 2 | 0 | 3.00 |
Ryan Specialty | 1 | 5 | 5 | 0 | 2.36 |
Roadzen presently has a consensus price target of $8.00, indicating a potential upside of 704.42%. Ryan Specialty has a consensus price target of $70.33, indicating a potential upside of 0.08%. Given Roadzen’s stronger consensus rating and higher probable upside, equities analysts plainly believe Roadzen is more favorable than Ryan Specialty.
Institutional and Insider Ownership
Volatility and Risk
Roadzen has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500. Comparatively, Ryan Specialty has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500.
Earnings and Valuation
This table compares Roadzen and Ryan Specialty”s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Roadzen | $50.04 million | 1.35 | -$99.67 million | ($3.00) | -0.33 |
Ryan Specialty | $2.08 billion | 8.81 | $61.04 million | $0.64 | 109.38 |
Ryan Specialty has higher revenue and earnings than Roadzen. Roadzen is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Roadzen and Ryan Specialty’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Roadzen | -287.82% | -31,166.20% | -221.81% |
Ryan Specialty | 10.21% | 48.08% | 6.57% |
Summary
Ryan Specialty beats Roadzen on 11 of the 14 factors compared between the two stocks.
About Roadzen
Roadzen, Inc., an insurtech company, provides various insurance products in the United States and internationally. It offers insurance as a service platform, including Via, which enables fleets, carmakers, and insurers to inspect a vehicle using computer vision; Global Distribution Network that enables the configuration, customer quote, payment, and administration of any insurance policy with any insurance carrier as the underwriter; xClaim, which enables digital, touchless, and real-time resolution of claims; StrandD, a digital, real-time dispatch, and tracking for roadside assistance and first notice of loss during accident claims; Good Driving that enables insurers and fleets to recognize drivers, train drivers, and build usage based insurance programs; and Drivebuddy AI, which provides driver-assistance capabilities. The company also provides insurance distribution platform that enables product creation and underwriting, re-insurer backing, and API exchange; and distribution, pre-inspection assistance, telematics, and roadside assistance. In addition, it offers insurance broker services. Roadzen, Inc. was founded in 2015 and is based in Burlingame, California.
About Ryan Specialty
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.
Receive News & Ratings for Roadzen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roadzen and related companies with MarketBeat.com's FREE daily email newsletter.